Reuters - Video

Edition: US | UK | IN | CN | JP

video Business

GSK buys Tesaro for $5.1 bln

Monday, December 03, 2018 - 01:15

UK's GlaxoSmithKline is buying U.S. cancer specialist Tesaro for $5.1 billion in a bid to rebuild the group's pharmaceuticals business. Fred Katayama reports.

▲ Hide Transcript

View Transcript

UK's GlaxoSmithKline is buying U.S. cancer specialist Tesaro for $5.1 billion in a bid to rebuild the group's pharmaceuticals business. Fred Katayama reports.

Press CTRL+C (Windows), CMD+C (Mac), or long-press the URL below on your mobile device to copy the code

GSK buys Tesaro for $5.1 bln

Monday, December 03, 2018 - 01:15